MIRA INFORM REPORT

 

 

 

Report Date :

26.06.2008

 

IDENTIFICATION DETAILS

 

Name :

INDUS BIOTECH PRIVATE LIMITED

 

 

Registered Office :

1, Rahul Residency, Plot No. 6 and 7, Off Salunke Vihar Road, Kondhwa, Pune – 411 048, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2007

 

 

Date of Incorporation :

16.02.1995

 

 

Com. Reg. No.:

11-85656

 

 

CIN No.:

[Company Identification No.]

U24231MH1995PTC085656

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

PNEI00601G

 

 

PAN No.:

[Permanent Account No.]

AAACI5708E

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Exporter of Herbal Extracts

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 350000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track. Trade relations are fair. General financial position is satisfactory. Payments are usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

 

INFORMATION PARTED BY

 

Name :

Mrs. Sharwari

Designation :

Accountant

Date :

23.06.2008

 

 

LOCATIONS

 

Registered Office :

1, Rahul Residency, Plot No. 6 and 7, Off Salunke Vihar Road, Kondhwa, Pune – 411 048, Maharashtra, India

Tel. No.:

91-20-24339323 / 64785063 / 64785064

E-Mail :

info@indusbiotech.com

Website :

www.indusbiotech.com

Area :

Approximately 3000 Sq. ft.

Location :

Owned

 

 

Factory  :

Perangut, Pune, Maharashtra, India

 

 

Branch Office :

# 58, 1161 Wayzata Blvd. East, Wayzata, MN, 5539, USA

Tel. No.:

+ 612 770 1197

Fax No.:

+ 1952 473 8324

E-Mail :

hame@indusbiotech.com

 

 

Branch Office :

Kaul Building, 8, Guru Nanak Nagar, Pune – 411 042, India

Tel. No.:

91-20-2643-5133 / 2643 4558

Fax No.:

91-20-2644 2829

E-Mail :

vinita@indusbiotech.com

 

 

Branch Office :

P. O. Box 49668, Hamiyah Free Zone, United, Arab Emirates

Tel. No.:

+ 97150 3604982

E-Mail :

roy@indusbiotech.com

 


 

DIRECTORS

 

Name :

Mr. Sunil Bhaskaran

Designation :

Chairman-Cum-Managing Director

Address :

Flat 1A, Anchor Heaven, S. No. 53 Part, Wanawadi, Pune – 411 040, Maharashtra, India

Date of Birth/Age :

30.11.1954

Date of Appointment :

16.02.1995

 

 

Name :

Mr. Ranjeet Srinivasan

Designation :

Director

Address :

A-3, Shankarshet Road, Pune – 411 042, Maharashtra, India

Date of Birth/Age :

15.06.1958

Date of Appointment :

16.02.1995

 

 

Name :

Mr. Rajan Srinivasan

Designation :

Whole Time Director

Address :

H. No.2965, 4th Cross, 12th Main Hal II Stage, Indira Nagar, Bangalore – 560 008, Karnataka, India

Date of Appointment :

01.01.2001

 

 

Name :

Mr. Kumund D Dalal

Designation :

Director

Address :

7 Sital Nagar 64, Walkeshwar Road, Mumbai – 400 006, Maharashtra, India

Date of Appointment :

06.12.2001

 

 

Name :

Dr. K. Venkat

Designation :

Director

Address :

62, Kings Belry Drive Someset, Newjercy 08873

Date of Appointment :

15.10.2002

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

(As on 21.09.2005)

Names of Shareholders

No. of Shares

Sunil Bhaskaran

44066

Ranjeet Srinivasan

59125

Thulasy Srinivasan

24211

Sunita Bhaskaran

50655

Rajan Srinivasan - HUF

110000

Mukund Dalal and Mrs. Dalal

5500

Anil Nanavati - HUF

7865

Kabir Mehta – Minor

2475

Rishi Mehta – Minor

2475

M/s Forward Issue Limited

7315

M/s Dodsal Private Limited

33000

Amruta Mudakavi

110

Kalpana Saralaya

110

Jayanthi Sachitanand

110

Roopal Gopaldas

110

Man Bahadur Lama

77

Kavenamma

55

R. J. Palat and Mrs. Mabelle Palat

110

Smita B Patel

1430

Rohit Hariram Israni

110

Debabrata Majumdar and Amruta Majumdar

3168

Pankaj Khandpur

110

Hansh Kattara

44000

Megatrade International SA

9185

 

 

Total

405372

 

Equity shares Breakup (percentage of total equity)

(As on 30.09.2007)

Category

Percentage

Venture Capital

0.19

Foreign holdings (Foreign institutional investor(s), Foreign companie (s), Foreign financial institution(s), Non-resident Indian(s) or Overseas corporate bodies or Others

9.33

Bodies Corporate

13.61

Directors or relatives of directors

58.33

Others

18.54

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Exporter of Herbal Extracts

 

 

Exports :

 

Countries :

U.S.A.

 

 

Terms :

 

Selling :

Credit (30 days / 60 days / 90 days)

 

 

Purchasing :

Credit (30 days / 60 days / 90 days)

 

 

GENERAL INFORMATION

 

No. of Employees :

42

 

 

Bankers :

Vijaya Bank

Sadashiv Peth, Pune – 411 030, Maharashtra, India

 

 

 

Banking Relations :

Satisfactory

 

 

Auditors :

 

Name :

N. M. Raiji and Company

Chartered Accountants

Address :

Universal Insurance Building, Pherozeshah Mehta Road, Mumbai – 400 001, Maharashtra, India

 

 

CAPITAL STRUCTURE

 

(As on 30.09.2007)

Authorised Capital :

No. of Shares

Type

Value

Amount

700000

Equity Shares

Rs.100/- each

Rs.70.000 millions

2700000

Preference Shares

Rs.100/- each

Rs.270.000 millions

 

 

 

 

 

Total

 

Rs.340.000 millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

525136

Equity Shares

Rs.100/- each

Rs.52.513 millions

2123083

Preference Shares

Rs.100/- each

Rs.212.308 millions

 

 

 

 

 

Total

 

Rs.264.821 millions

 


 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2007

31.03.2006

31.03.2005

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

49.748

45.455

40.537

2] Share Application Money

3.364

0.000

0.000

3] Reserves & Surplus

16.469

9.561

4.865

4] (Accumulated Losses)

0.000

0.000

(7.690)

NETWORTH

69.581

55.016

37.712

LOAN FUNDS

 

 

 

1] Secured Loans

0.238

0.960

0.920

2] Unsecured Loans

4.900

1.900

1.900

TOTAL BORROWING

5.138

2.860

2.820

DEFERRED TAX LIABILITIES

1.599

0.242

0.230

 

 

 

 

TOTAL

76.318

58.118

40.762

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

60.858

20.626

9.511

Capital work-in-progress

6.211

35.308

30.914

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

14.693

2.949

5.557

 

Sundry Debtors

4.253

17.326

2.360

 

Cash & Bank Balances

1.998

5.246

1.130

 

Other Current Assets

0.042

0.029

0.000

 

Loans & Advances

10.578

3.294

1.889

Total Current Assets

31.564

28.844

10.936

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

19.928

23.637

10.417

 

Provisions

2.439

3.034

0.282

Total Current Liabilities

22.367

26.671

10.699

Net Current Assets

9.197

2.173

0.237

 

 

 

 

MISCELLANEOUS EXPENSES

0.052

0.011

0.100

 

 

 

 

TOTAL

76.318

58.118

40.762

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2007

31.03.2006

31.03.2005

Debt Equity Ratio

(Total Liability/Networth)

 

0.40

0.54

0.34

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.41

1.08

1.02

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Trade References :

 

·         J. B. Chemicals – Pune

·         Jaya Industries - Mumbai

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.42.82

UK Pound

1

Rs.84.27

Euro

1

Rs.66.62

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

45

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions